Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized as a betacoronavirus and recognized as the seventh discrete coronavirus species capable of causing human disease. This new coronavirus causes febrile respiratory illness and on March 11, 2020, was characterized as a global pandemic. Investigators have accelerated the search for a vaccine to prevent infection and for agents to treat it. This article presents those drug targets that (as of March 20, 2020) are currently under active investigation for the treatment of COVID-19, the disease caused by SARS-CoV-2 infection.